glp-1 antagonist Complementary Yet Distinct Roles of Receptor Agonists and SGLT2 Inhibitors in Cardiovascular Risk Reduction GLP-1 receptor agonists and next-generation

We continue to believe that if market-based data (median payer-specific negotiated charges for MA organizations) are incorporated into the calculation of the MS-DRG relative weights, initially there will be limited impact on the relative weights given the current similarity between MA organization rates and Medicare FFS rates, but that over time the proposal would create an opportunity for negotiations to reflect market dynamics, as noted by a commenter who supported our proposed policy

When patients present with concerning symptoms whilst taking B12 supplements, alternative diagnoses should be considered, including allergic reactions to supplement excipients, interactions with other medications, or coincidental illness

Cao G, Chen B, Zhang X, Chen H

The ORYN pre-mixed pen has cut our preparation time by 90% and improved our dose-to-dose consistency

Data availability All relevant data are available from the corresponding authors upon reasonable request

12 week cycle is optimal with 4-6 week break then start over as needed